Annual D&A
$236.19M$6.79M+2.96%
Summary
- Current Value
- As of today, AMRX annual D&A is $236.19M, up +2.96% on
- Historical Performance
- AMRX annual D&A is up +1.19% over the past 3 years, and up +13.97% over the past 5 years
- All-Time High Comparison
- AMRX annual D&A is currently -1.66% below its historical high of $240.18M set on
- 3-Year Low Comparison
- AMRX annual D&A is +2.96% above its 3-year low of $229.40M reached on
- Sector Comparison
- AMRX annual D&A is higher than 92.51% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $236.19M | +3.0% | +1.2% | +14.0% | +1996.5% | |
| Quarterly D&A | $54.07M | -8.3% | -12.2% | -8.9% | +1703.6% | |
| TTM D&A | $240.48M | +5.9% | +0.1% | +4.6% | +1819.8% | |
| Price | $13.26 | +68.5% | +500.0% | +167.3% | – | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $2.91B | +17.5% | +39.7% | +46.4% | +844.0% | |
| Annual Operating Expenses | $667.15M | +12.4% | +17.6% | +39.7% | +547.8% | |
| Annual Revenue | $2.79B | +16.7% | +33.5% | +71.8% | +679.5% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $240.18M | N/A | -1.7% |
| 5Y | $240.18M | -1.7% | |
| All | $240.18M | -1.7% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $229.40M | +3.0% | |
| 5Y | $229.40M | +3.0% | |
| All | $708.00K | >+9999.0% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of AMRX?
As of today, AMRX annual D&A is $236.19M
What is 1-year change in AMRX annual D&A?
AMRX annual D&A is up +2.96% year-over-year
What is 3-year change in AMRX annual D&A?
AMRX annual D&A is up +1.19% over the past 3 years
How far is AMRX annual D&A from its all-time high?
AMRX annual D&A is currently -1.66% below its historical high of $240.18M set on December 31, 2022
How does AMRX annual D&A rank versus sector peers?
AMRX annual D&A is higher than 92.51% of companies in Healthcare sector
When is AMRX next annual earnings release?
The next annual earnings release for AMRX is on
Quarterly D&A
$54.07M$6.04M-10.05%
Summary
- Current Value
- As of today, AMRX quarterly D&A is $54.07M, down -10.05% on
- Historical Performance
- AMRX quarterly D&A is down -8.29% year-over-year, and down -12.23% over the past 3 years
- All-Time High Comparison
- AMRX quarterly D&A is currently -18.23% below its historical high of $66.13M set on
- 3-Year Low Comparison
- AMRX quarterly D&A is at its 3-year low
- Sector Comparison
- AMRX quarterly D&A is higher than 90.95% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $54.07M | -10.1% | -8.3% | -12.2% | -8.9% | |
| Annual D&A | $236.19M | – | +3.0% | +1.2% | +14.0% | |
| TTM D&A | $240.48M | -2.0% | +5.9% | +0.1% | +4.6% | |
| Price | $13.26 | +28.0% | +68.5% | +500.0% | +167.3% | |
| Quarterly SG&A | $137.82M | +10.9% | +16.1% | +37.7% | +65.8% | |
| Quarterly Total Expenses | $782.14M | +11.4% | +11.3% | +42.7% | +48.1% | |
| Quarterly Operating Expenses | $201.17M | +16.8% | +11.9% | +33.8% | +57.6% | |
| Quarterly Revenue | $784.51M | +8.3% | +11.7% | +43.8% | +51.1% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $66.13M | N/A | -18.2% |
| 3Y | $66.13M | -18.2% | |
| 5Y | $66.13M | -18.2% | |
| All | $66.13M | -18.2% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $54.07M | at low | |
| 3Y | $54.07M | at low | |
| 5Y | $54.07M | at low | |
| All | -$4.62M | +1271.7% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of AMRX?
As of today, AMRX quarterly D&A is $54.07M
What is AMRX quarterly D&A most recent change?
AMRX quarterly D&A was down -10.05% on September 30, 2025
What is 1-year change in AMRX quarterly D&A?
AMRX quarterly D&A is down -8.29% year-over-year
How far is AMRX quarterly D&A from its all-time high?
AMRX quarterly D&A is currently -18.23% below its historical high of $66.13M set on December 31, 2024
How does AMRX quarterly D&A rank versus sector peers?
AMRX quarterly D&A is higher than 90.95% of companies in Healthcare sector
When is AMRX next earnings release?
The next earnings release for AMRX is on
TTM D&A
$240.48M$4.89M-1.99%
Summary
- Current Value
- As of today, AMRX TTM D&A is $240.48M, down -1.99% on
- Historical Performance
- AMRX TTM D&A is up +5.94% year-over-year, and up +0.07% over the past 3 years
- All-Time High Comparison
- AMRX TTM D&A is currently -1.99% below its historical high of $245.36M set on
- 3-Year Low Comparison
- AMRX TTM D&A is +6.76% above its 3-year low of $225.24M reached on
- Sector Comparison
- AMRX TTM D&A is higher than 91.83% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $240.48M | -2.0% | +5.9% | +0.1% | +4.6% | |
| Annual D&A | $236.19M | – | +3.0% | +1.2% | +14.0% | |
| Quarterly D&A | $54.07M | -10.1% | -8.3% | -12.2% | -8.9% | |
| Price | $13.26 | +28.0% | +68.5% | +500.0% | +167.3% | |
| TTM SG&A | -$2.34B | -578.5% | -613.3% | -693.9% | -841.6% | |
| TTM Revenue | $2.93B | +2.9% | +9.5% | +37.2% | +56.1% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $245.36M | -2.0% | |
| 3Y | $245.36M | -2.0% | |
| 5Y | $245.36M | -2.0% | |
| All | $245.36M | -2.0% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $236.19M | N/A | +1.8% |
| 3Y | $225.24M | +6.8% | |
| 5Y | $225.24M | +6.8% | |
| All | $177.00K | >+9999.0% |
TTM D&A History
FAQ
What is the current TTM D&A of AMRX?
As of today, AMRX TTM D&A is $240.48M
What is AMRX TTM D&A most recent change?
AMRX TTM D&A was down -1.99% on September 30, 2025
What is 1-year change in AMRX TTM D&A?
AMRX TTM D&A is up +5.94% year-over-year
How far is AMRX TTM D&A from its all-time high?
AMRX TTM D&A is currently -1.99% below its historical high of $245.36M set on June 30, 2025
How does AMRX TTM D&A rank versus sector peers?
AMRX TTM D&A is higher than 91.83% of companies in Healthcare sector
When is AMRX next earnings release?
The next earnings release for AMRX is on
Data Sources & References
- AMRX Official Website www.amneal.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1723128/000172312825000059/0001723128-25-000059-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1723128/000172312825000012/0001723128-25-000012-index.htm
- AMRX Profile on Yahoo Finance finance.yahoo.com/quote/AMRX
- AMRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amrx